Canakinumab eliminates resistant familial Mediterranean fever in a Japanese girl

Pediatr Int. 2019 Nov;61(11):1173-1174. doi: 10.1111/ped.13968. Epub 2019 Nov 13.

Authors

Ryosuke Yasuda^{1

2}, Tatsuki Mizuochi¹, Miyuki Kitamura^{1

2}, Kiyoshi Migita^{3

4}, Yushiro Yamashita¹

Affiliations

¹ Department of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
² Department of Pediatrics, St Mary's Hospital, Kurume, Fukuoka, Japan.
³ Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan.
⁴ Clinical Research Center, NHO Nagasaki Medical Center, Omura, Nagasaki, Japan.

PMID: 31724243
DOI: 10.1111/ped.13968

No abstract available

Keywords: canakinumab; children; colchicine-resistant familial Mediterranean fever.

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal, Humanized / administration & dosage*
Child
Colchicine / therapeutic use
Drug Resistance
Familial Mediterranean Fever / drug therapy*
Female
Humans
Japan
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
canakinumab
Colchicine